Coloboma of the eye, heart defects, atresia of the nasal choanae, retardation of growth and/or development, genital abnormalities and ear abnormalities and deafness (CHARGE) syndrome is a highly variable, multiple congenital anomaly syndrome with an estimated prevalence of 1 in 17 000. The main features are hypoplasia of the semicircular canals, coloboma, choanal atresia, heart defects, hypogonadotropic hypogonadism, ear malformations, deafness, cranial nerve dysfunction and cleft/lip palate. The phenotype shows a remarkable variability that cannot be explained by different genotypes. In most patients a
de novo
autosomal dominant loss‐of‐function mutation of chromodomain helicase
deoxyribonucleic acid
(DNA)‐binding gene 7 (
CHD7
) is found. The CHD protein family plays a role in transcription regulation by chromatin remodelling. Expression studies as well as studies in stem cells, neural crest cells and animal models have revealed that CHD7 has a tissue‐ and embryonic stage‐specific function in enhancer‐mediated transcription. The broad phenotypic spectrum involving many organ systems that is seen in CHD7 haploinsufficiency can be explained by cell type‐specific binding sites, protein complexes and target genes of CHD7.
Key Concepts:
CHARGE syndrome is a multiple congenital anomaly syndrome with a highly variable and broad clinical spectrum.
CHARGE syndrome shows remarkable clinical overlap with other multiple congenital anomaly syndromes. In contrast,
CHD7
mutations do not cause nonsyndromic congenital defects.
CHD7
is the main causal gene in CHARGE syndrome and codes for a chromodomain protein.
Chromodomain proteins are important during embryonic development.
CHD7 has a function in enhancer‐mediated transcription.
Both the expression of CHD7 and its binding sites to genomic enhancer regions are cell type‐ and embryonic stage‐dependent.
CHD7 haploinsufficiency alters transcription of tissue‐specific target genes that are normally regulated by CHD7 or complexes in which CHD7 is involved.
CHD7 plays an important role in neural crest cells and the interaction of the neural crest with other tissues.
Investigation of overlapping phenotypes and converging molecular pathways gives insight into the pathogenesis.